The NIH is the largest supporter of biomedical research in the world and provided more than $170 million in funding for Ohio State in 2017.
Collins' visit came a day after lawmakers in Congress unveiled a spending bill that includes an additional $500 million for new opioid research by the NIH, money he says will be used to inspire investigators all over the country to come forward with their best ideas.
I've just spent the last couple of hours meeting with some of the researchers here who are tackling this problem from a variety of different directions, he said, referring to a roundtable discussion earlier in the day. I'm very impressed and gratified to see the kind of creativity, energy, and resources that are being put into this.
Executive Vice President and Provost Bruce A. McPheron announced the creation of the $1.35 million Opioid Innovation Fund in October. Interdisciplinary teams of faculty and staff were encouraged to leverage existing public and private partnerships, particularly with community organizations such as local faith-based groups and non-profits, governmental agencies, libraries and businesses. The criteria imposed few restrictions on the use of funds but did emphasize the need for sustainable programs that could be quickly implemented and thoroughly evaluated as they grew.
Of 89 pre-proposals submitted, 32 were recommended for final submission after peer review. A panel of independent evaluators determined the final ranking among the 28 proposals that were ultimately submitted. The eight teams will share grants totaling nearly $500,000. A second round of funding is planned for late fall.
It is in our interest to build an infrastructure that supports everyone at Ohio State who wants to move forward with programs or new research efforts that will address the opioid crisis, Martin said. That is our shared responsibility. And I can assure you that in my remaining days at Ohio State, this is going to be an extremely high priority.
For several years, Ohio State has been addressing the opioid crisis through multiple channels, including the Wexner Medical Center, Ohio State Extension, and programs in many of the colleges, an approach Martin says reflects the exceptional interdisciplinary strength of Ohio State as a land-grant university.
A PDF summarizing the eight winning proposals is available to download here.
Written by Tom Rinderle, Office of Academic Affairs
Frequently Asked Questions
We anticipate that a second round of applications for OIF support will be due in fall 2018. Details will be posted here, on the Opioid Innovation Fund webpage, as they become available. Look for announcements in OnCampus and other university news outlets as we get closer to the date.
Eighty-nine pre-proposals were submitted, and 32 were recommended for final submission. Twenty-eight were ultimately submitted. From this group, two proposals were chosen for implementation grants of up to $100,000, and six for planning grants of up to $50,000.
A panel of several independent reviewers evaluated and ranked the proposals. The review followed the traditional NIH review format and used the 1-9 scale of ranking.
All of the submissions reflected innovative ideas, but the selected proposals were notable because they addressed an important need related to the opioid crisis and offered a clear plan for evaluation of the project and its potential for broader implementation.
We are dedicated to helping develop the many innovative ideas that were not funded in the first round. The OIF Grant Support Team will be hosting a grant development workshop prior to the next submission deadline. Please watch the OIF webpage and OnCampus for dates.
Yes! The principal investigators on each grant will be receiving reviewer feedback via email.
Grant guidelines and the application timeline for the first round of funding in March 2018 remain published online and are accesible using the link immediately below. It's possible that guidelines might be revised in some fashion for the second round.